BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3910797)

  • 1. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
    Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
    J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan.
    Chipkin RE; Latranyi MZ; Iorio LC; Barnett A
    Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
    Yaksh TL; Harty GJ
    Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.
    Chipkin RE; Kreutner W; Billard W
    Eur J Pharmacol; 1984 Jun; 102(1):151-4. PubMed ID: 6383841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL; Mendelsohn LG; Cohen ML; Evans DA; Frederickson RC
    Life Sci; 1985 Apr; 36(13):1307-13. PubMed ID: 2984500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice.
    Roques BP; FourniƩ-Zaluski MC; Soroca E; Lecomte JM; Malfroy B; Llorens C; Schwartz JC
    Nature; 1980 Nov; 288(5788):286-8. PubMed ID: 7001254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T; Becker FT; Sybertz EJ; Sabin C; Desiderio DM
    Eur J Pharmacol; 1983 Oct; 94(1-2):85-91. PubMed ID: 6360696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
    Reggiani A; Carenzi A; Frigeni V; Della Bella D
    Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; FourniƩ-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan, are enhanced in arthritic rats.
    Kayser V; Guilbaud G
    Brain Res; 1983 May; 267(1):131-8. PubMed ID: 6574799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiorphan potentiation of stress-induced analgesia in the mouse.
    Greenberg R; O'Keefe EH
    Life Sci; 1982 Sep 20-27; 31(12-13):1185-8. PubMed ID: 6755120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
    Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
    Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E
    Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone.
    Chipkin RE; Latranyi MB; Iorio LC
    Life Sci; 1982 Sep 20-27; 31(12-13):1189-92. PubMed ID: 6958954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive effects of morphine and of an enkephalinase inhibitor on responses of ventro-basal thalamic neurones to noxious stimuli.
    Guilbaud G; Kayser V; Benoist JM; Gautron M
    Life Sci; 1983; 33 Suppl 1():545-7. PubMed ID: 6363853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical dependence produced by chronic intracerebroventricular infusion of [D-Arg]kyotorphin or thiorphan to rats.
    Bean AJ; Vaught JL
    Eur J Pharmacol; 1984 Oct; 105(3-4):333-7. PubMed ID: 6096157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Suh HH; Tseng LL
    Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.